The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection

The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection

AbstractAim A third (booster) dose of the anti-SARS-CoV-2 vaccine became necessary due to the observed decrease in anti-SARS-CoV-2S antibody levels over time, new mutations, and low global vaccination rates. In this study, anti-SARS-CoV-2S antibody levels were measured (ECLIA assay) in 50 healthcare...

Full description

Bibliographic Details
Main Authors: Blanka Wolszczak-Biedrzycka, Anna Bieńkowska, Beata Cieślikiewicz, Elwira Smolińska-Fijołek, Grzegorz Biedrzycki, Justyna Dorf
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
Third dose of BNT162b2
COVID-19
healthcare workers
anti-SARS-CoV-2S antibodies
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2182907

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2023.2182907

Similar Items